This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Sandoz Ag. Active years: 2015-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015-2017
Title: Innovations of Robert Mayer
Introduction
Robert Mayer is an accomplished inventor based in Kundl, Austria. He has made significant contributions to the field of therapeutic applications through his innovative work. With a total of 2 patents, Mayer has focused on enhancing the understanding and purification of fusion proteins.
Latest Patents
Mayer's latest patents include the "Quantification of misfolded TNFR2:Fc." This invention is directed to methods for determining the relative amount of wrongly disulphide bridged TNFR2:Fc in a sample. TNFR2:Fc is a fusion protein that is utilized in various therapeutic applications. The invention also pertains to a method for purifying TNFR2:Fc using the aforementioned method, leading to improved TNFR2:Fc compositions.
Career Highlights
Robert Mayer is currently associated with Sandoz AG, where he continues to innovate in the field of biopharmaceuticals. His work has been instrumental in advancing therapeutic methods and enhancing the efficacy of fusion proteins.
Collaborations
Mayer has collaborated with notable colleagues, including Alfred Rupprechter and Michael Fuchs. These collaborations have further enriched his research and development efforts.
Conclusion
Robert Mayer's contributions to the field of therapeutic applications through his patents and collaborations highlight his role as a significant inventor. His work continues to impact the biopharmaceutical industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile